Results 201 to 210 of about 64,130 (263)
Prenatally Diagnosed 7q11.23 Copy Number Variations: A Retrospective Case Series
Prenatal 7q11.23 CNVs exhibit 100% ultrasound anomalies in deletions (cardiovascular defects, growth restriction) and 50% in duplications. Inherited CNVs (50% deletions, 43% duplications) correlate with milder outcomes, while de novo variants drive high TOP rates (76.5%), emphasizing genomic testing and parental studies for precise counseling. ABSTRACT
Jiong Yan, Ziyang Liu, Song Yi, Nian Liu
wiley +1 more source
β2-Adrenoceptors and GRK2 as Potential Biomarkers in Patients With Chronic Pulmonary Regurgitation. [PDF]
Rodriguez-Serrano M +8 more
europepmc +1 more source
Abstract Purpose This study investigated the effect of bicuspid aortic valve (BAV) morphology and ascending aortic curvature (AAAc) bending angles on aortic hemodynamics, focusing on transvalvular jets and secondary helical flows that contribute to systolic hemodynamic stress linked to aortic complications.
Kaoru Hattori +6 more
wiley +1 more source
Echocardiographic parameters of severe pulmonary regurgitation after surgical repair of tetralogy of Fallot. [PDF]
Van Berendoncks A +9 more
europepmc +1 more source
The Use of Treprostinil for Bronchopulmonary Dysplasia Associated Pulmonary Hypertension
ABSTRACT Background Treprostinil for the treatment of bronchopulmonary dysplasia‐associated pulmonary hypertension (BPD‐PH) has previously been described in small cohort studies, often used later in the course after failure to improve on other therapies.
Stephanie M. Tsoi +8 more
wiley +1 more source
ABSTRACT Exercise testing has long been essential for evaluating diagnosis, prognosis, and functional status in pulmonary hypertension (PH). Recent advances have clarified its role in defining reference values and prognostic markers. Nonetheless, substantial knowledge gaps persist regarding the implementation of invasive cardiopulmonary exercise ...
Aaron B. Waxman +20 more
wiley +1 more source
Subcutaneous Treprostinil in PH Associated With Left Heart Disease or Chronic Lung Disease
ABSTRACT Pulmonary hypertension (PH) associated with left heart disease (LHD‐PH) and pulmonary hypertension associated with chronic lung disease (CLD‐PH) are the most common PH subtypes but lack effective treatments. In a prospective cohort study, 90 patients (39 LHD‐PH, 51 CLD‐PH) with severe disease [pulmonary vascular resistance (PVR) > 5 Wood units
Roela Sadushi‐Koliçi +8 more
wiley +1 more source

